We make them accessible.
It’s also the science.
Panaxia continues its upward trend: Ends Q3 with record revenues of 16.8 million and 300% growth over the previous year
December 1, 2020| Yahoo Finance TEL AVIV, Israel, Dec. 1, 2020 /PRNewswire/ — The Israeli subsidiary of Panaxia Global, Panaxia Labs Israel Ltd. (“Panaxia Israel”) (TASE: PNAX), Israel’s largest manufacturer of medical
November 23, 2020 | BENZINGA Israel medical cannabis producer Panaxia Labs Israel (TASE:PNAX) and European pharmaceutical company Neuraxpharm are planning to reach the French market. The two companies have agreed to a production,
November 18, 2020 |Jpost Panaxia, in cooperation with Seach Medical Group, two of Israel’s largest manufacturers of medical cannabis products, announced that the country’s first commercial export
Panaxia is the first Israeli company to receive a marketing permit for medical cannabis products in Germany
November 9, 2020 | MarketWatch The Israeli subsidiary of Panaxia Global, Panaxia Labs Israel Ltd.(Panaxia Israel) (TASE: PNAX), Israel’s largest medical cannabis manufacturer and Neuraxpharm, its partner, Europe’s largest
Panaxia continues to grow: Panaxia Global Reports that Panaxia Israel ended the 3rd quarter of 2020 with record revenues of at least 16.3 million
October 12, 2020| Yahoo Finance Completes 12 consecutive quarters of revenue increase Projects to complete the first nine months with revenues of at least 43.2 million,
August 31, 2020| Yahoo Finance In the first half of 2020, the company exceeded its full-year revenues in 2019 with record revenues of 26.9 million, over